Qing Xi
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Circular RNAs in diseases 3
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Rongxin Zhang (14 shared papers)Zhenyi Xue (8 shared papers)Yurong Da (6 shared papers)Zimu Zhang (6 shared papers)Jieyou Zhang (8 shared papers)Hongkun Liu (5 shared papers)X. Edward Guo (5 shared papers)Guangze Yang (8 shared papers)
- Journals
- Nature Communications (2 papers)Cancer Biology and Medicine (2 papers)International Immunopharmacology (2 papers)Autophagy (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Qing Xi
31 papers receiving 1.0k citations
Qing Xi's Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 321
- Immunology 311
- Oncology 217
- Molecular Biology 546
- Hematology 42
Countries citing papers authored by Qing Xi
This map shows the geographic impact of Qing Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Xi more than expected).
Fields of papers citing papers by Qing Xi
This network shows the impact of papers produced by Qing Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Xi. The network helps show where Qing Xi may publish in the future.
Co-authors
The 25 scholars most cited alongside Qing Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 142 | |
| 2 | 2018 | 127 | |
| 3 | 2019 | 116 | |
| 4 | 2002 | 94 | |
| 5 | Immune checkpoint inhibitors: breakthroughs in cancer treatment Hit paper breakdown → | 2024 | 61 |
| 6 | 2020 | 50 | |
| 7 | 2011 | 47 | |
| 8 | 2020 | 42 | |
| 9 | 2015 | 41 | |
| 10 | 2017 | 41 | |
| 11 | 2021 | 31 | |
| 12 | 2021 | 30 | |
| 13 | 2022 | 30 | |
| 14 | 2019 | 28 | |
| 15 | 2023 | 25 | |
| 16 | 2012 | 17 | |
| 17 | 2024 | 16 | |
| 18 | 2021 | 15 | |
| 19 | 2016 | 13 | |
| 20 | 2007 | 11 |
About Qing Xi
Qing Xi is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Epidemiology, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), MicroRNA in disease regulation (4 papers), Phagocytosis and Immune Regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Oral microbiology and periodontitis research (4 papers), Circular RNAs in diseases (3 papers), Immune Cell Function and Interaction (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cancer Research (321 citations), Immunology (311 citations), Oncology (217 citations), Molecular Biology (546 citations) and Hematology (42 citations). Qing Xi has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Rongxin Zhang, Zhenyi Xue, Yurong Da, Zimu Zhang, Jieyou Zhang, Hongkun Liu, X. Edward Guo, Guangze Yang, Zhi Yao and Lijuan Zhang. Their work appears in journals such as Nature Communications, Cancer Biology and Medicine, International Immunopharmacology, Autophagy and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.